乳钵 发表于 2025-3-21 19:28:00

书目名称Biomarkers for Alzheimer’s Disease Drug Development影响因子(影响力)<br>        http://impactfactor.cn/if/?ISSN=BK0187795<br><br>        <br><br>书目名称Biomarkers for Alzheimer’s Disease Drug Development影响因子(影响力)学科排名<br>        http://impactfactor.cn/ifr/?ISSN=BK0187795<br><br>        <br><br>书目名称Biomarkers for Alzheimer’s Disease Drug Development网络公开度<br>        http://impactfactor.cn/at/?ISSN=BK0187795<br><br>        <br><br>书目名称Biomarkers for Alzheimer’s Disease Drug Development网络公开度学科排名<br>        http://impactfactor.cn/atr/?ISSN=BK0187795<br><br>        <br><br>书目名称Biomarkers for Alzheimer’s Disease Drug Development被引频次<br>        http://impactfactor.cn/tc/?ISSN=BK0187795<br><br>        <br><br>书目名称Biomarkers for Alzheimer’s Disease Drug Development被引频次学科排名<br>        http://impactfactor.cn/tcr/?ISSN=BK0187795<br><br>        <br><br>书目名称Biomarkers for Alzheimer’s Disease Drug Development年度引用<br>        http://impactfactor.cn/ii/?ISSN=BK0187795<br><br>        <br><br>书目名称Biomarkers for Alzheimer’s Disease Drug Development年度引用学科排名<br>        http://impactfactor.cn/iir/?ISSN=BK0187795<br><br>        <br><br>书目名称Biomarkers for Alzheimer’s Disease Drug Development读者反馈<br>        http://impactfactor.cn/5y/?ISSN=BK0187795<br><br>        <br><br>书目名称Biomarkers for Alzheimer’s Disease Drug Development读者反馈学科排名<br>        http://impactfactor.cn/5yr/?ISSN=BK0187795<br><br>        <br><br>

lactic 发表于 2025-3-21 22:00:02

http://reply.papertrans.cn/19/1878/187795/187795_2.png

诙谐 发表于 2025-3-22 03:59:55

http://reply.papertrans.cn/19/1878/187795/187795_3.png

vasospasm 发表于 2025-3-22 04:34:51

Joachim Tries,Rüdiger Reinhardt, an update on advanced systems biology methods and strategies for holistic studies of multifactorial diseases—particularly AD—is presented. This includes next-generation genomics, neuroimaging and multi-omics methods, experimental and computational approaches, relevant disease models, and latest ge

asthma 发表于 2025-3-22 12:33:12

Joachim Tries,Rüdiger Reinhardtate for an efficient primary care management. A limitation to the development of a large-scale blood-screening biomarker-based test is the traditional application of clinically descriptive criteria for the categorization of single late-stage ND constructs. These are genetically and biologically hete

我不重要 发表于 2025-3-22 14:38:06

Perspektiven kritischer Sozialer Arbeitseful tool when the cause for dementia remains unclear and different diagnosis would lead to different treatment approaches. Due to the lack of treatment options in pre-dementia stages, the use of .F-FDG PET is currently not recommended for these cases in a purely clinical setting.

尽责 发表于 2025-3-22 19:59:36

http://reply.papertrans.cn/19/1878/187795/187795_7.png

可忽略 发表于 2025-3-22 21:38:09

http://reply.papertrans.cn/19/1878/187795/187795_8.png

衰弱的心 发表于 2025-3-23 03:25:23

http://reply.papertrans.cn/19/1878/187795/187795_9.png

催眠药 发表于 2025-3-23 07:51:12

http://reply.papertrans.cn/19/1878/187795/187795_10.png
页: [1] 2 3 4 5
查看完整版本: Titlebook: Biomarkers for Alzheimer’s Disease Drug Development; Robert Perneczky Book 2018 Springer Science+Business Media, LLC 2018 Alzheimer’s dise